Eyesight in MS protected by epilepsy drug
by Bruce Sylvester: Phenytoin, a drug used to prevent seizures in epilepsy, appears to help protect the eyesight of persons with multiple sclerosis (MS). Researchers reported this finding… read more.
by Bruce Sylvester: Phenytoin, a drug used to prevent seizures in epilepsy, appears to help protect the eyesight of persons with multiple sclerosis (MS). Researchers reported this finding… read more.
by Bruce Sylvester: Ranibizumab (Lucentis®) therapy appears to have efficacy in reversing diabetes-related vision loss in some populations, researchers reported online on Feb. 19 in the journal Opthalmology.
Sustained release treatment option could soon be available for diabetic patients in 28 countries of the European Union.
by Bruce Sylvester – Less than half of Americans with eye damage caused by diabetes are aware of the connection between diabetes and visual impairment, researchers reported online… read more.
Investigators reported on Oct. 22 in the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) that treatment with adalimumab may be effective for patients with steroid-resistant… read more.
Patients who are otherwise completely unable to communicate can answer yes or no questions within seconds with the help of a simple system—consisting of just a laptop and… read more.
FDA Highlights by Bruce Sylvester – Researchers from the Massachusetts Eye and Ear, Harvard Medical School, and Brigham and Women’s hospital in Boston, Massachusetts report that topical anakinra,… read more.
An international group of investigators has identified seven new genetic regions associated with age-related macular degeneration (AMD), a common cause of blindness in older individuals. The findings could… read more.
by Gary Finnegan – World Health Matters (Japan) – Researchers in Japan have called for mandatory visual field testing for drivers in light of evidence showing glaucoma may… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.